论文部分内容阅读
通过对我国传统中药受阻于《欧盟传统植物药注册程序指令》原因的分析,结合欧盟对植物药在欧盟注册程序的具体要求,寻找我国中药再次突围欧盟市场的可能及方法,为中药产业今后进军欧盟市场提供参考。
By analyzing the reasons why traditional Chinese traditional medicine was blocked in the EU Directive on the Registration of Traditional Botanical Medicines and the specific requirements of the European Union for the registration of botanical drugs in the EU and looking for the possibility and method for Chinese traditional medicine to break through the EU market again, EU market for reference.